TeleClinic review
Each molecule starts on a discounted first quarter billed quarterly, and the standard monthly rate is stated beside it.
The verdict
TeleClinic publishes standard member rates of $199 a month for semaglutide and $299 for tirzepatide. Each starts on an introductory first quarter, billed quarterly. Coverage is 47 states.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- States
- 47
- From
- From $199/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- 47 states
TeleClinic sells both molecules by injection. Each has an introductory first-quarter rate and a standard monthly rate, and both are stated in one FAQ answer.
Who writes the prescription, and what do they see?
A prescription precedes shipping. The member framing implies a continuing relationship rather than a transaction. What that membership includes beyond the medication is not itemized.
Stating the standard rate beside the introductory one is the useful part. A buyer can see month four's bill before paying for month one. The introductory rate is billed as a quarter, so it is a three-month commitment.
What happens when the dose goes up?
Nothing is published about what the standard rate does at a higher dose. No milligram figure appears beside either rate.
What the price includes
Semaglutide is $139 a month for the first quarter, billed quarterly, then $199 a month. Tirzepatide is $219 a month for the first quarter, then $299. Six months of semaglutide at those rates is $1,014. Tirzepatide costs $100 a month more at the standard rate.
What it claims, and what it cites
Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
Where it holds up, and where it does not
- Strength: The standard rate is stated beside the intro rate
- Strength: Both molecules priced in one answer
- Strength: Coverage across 47 states
- Limitation: The introductory rate needs a quarter billed at once
- Limitation: What membership includes is not itemized
- Limitation: No dose behavior is published
- Limitation: No compounding pharmacy is named
What the evidence says about this kind of treatment
The assessment above is about TeleClinic. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants the standard rate stated before signing up for the introductory quarter.
- Wrong for
- A reader who needs the rate at a higher dose established first.
The evidence behind what TeleClinic prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How TeleClinic compares
| Seller | Who it suits | Go |
|---|---|---|
 TeleCareSpot | Readers confident of approval who want a flat all-in rate | See TeleCareSpot → |
 The Edit | Readers who read the standing rate beside the first-order figure | See The Edit → |
 TMates | Readers choosing between formats who do not want the choice priced | See TMates → |
More GLP-1 telehealth sellers reviews: YOURx HealthYouth & SoulZenbodyCoby HealthForm HealthPepton Health
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Does tirzepatide cost more?
- Yes. The standard rate is $299 a month for tirzepatide against $199 for semaglutide.
- What does the first quarter cost?
- $139 a month for semaglutide and $219 a month for tirzepatide, billed quarterly. The standard rate applies after that.
- Where does TeleClinic operate?
- Forty-seven states are recorded in its coverage list.
- Is TeleClinic legit?
- TeleClinic is a GLP-1 telehealth sellers service. Its stated availability: 47 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is TeleClinic expensive compared with other GLP-1 telehealth sellers?
- TeleClinic publishes a starting figure of $199/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts TeleClinic above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.